BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 20388801)

  • 1. Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis.
    Garmy-Susini B; Avraamides CJ; Schmid MC; Foubert P; Ellies LG; Barnes L; Feral C; Papayannopoulou T; Lowy A; Blair SL; Cheresh D; Ginsberg M; Varner JA
    Cancer Res; 2010 Apr; 70(8):3042-51. PubMed ID: 20388801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI3Kα activates integrin α4β1 to establish a metastatic niche in lymph nodes.
    Garmy-Susini B; Avraamides CJ; Desgrosellier JS; Schmid MC; Foubert P; Ellies LG; Lowy AM; Blair SL; Vandenberg SR; Datnow B; Wang HY; Cheresh DA; Varner J
    Proc Natl Acad Sci U S A; 2013 May; 110(22):9042-7. PubMed ID: 23671068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin α4 Induces Lymphangiogenesis and Metastasis via Upregulation of VEGF-C in Human Colon Cancer.
    Lv XH; Liu BQ; Li XM; Wang XC; Li XL; Ahmed N; Zhang YF
    Anat Rec (Hoboken); 2016 Jun; 299(6):741-7. PubMed ID: 26917449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
    García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
    J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
    Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNFR1 mediates TNF-α-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling.
    Ji H; Cao R; Yang Y; Zhang Y; Iwamoto H; Lim S; Nakamura M; Andersson P; Wang J; Sun Y; Dissing S; He X; Yang X; Cao Y
    Nat Commun; 2014 Sep; 5():4944. PubMed ID: 25229256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis.
    Lahdenranta J; Hagendoorn J; Padera TP; Hoshida T; Nelson G; Kashiwagi S; Jain RK; Fukumura D
    Cancer Res; 2009 Apr; 69(7):2801-8. PubMed ID: 19318557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin alpha4beta1 promotes monocyte trafficking and angiogenesis in tumors.
    Jin H; Su J; Garmy-Susini B; Kleeman J; Varner J
    Cancer Res; 2006 Feb; 66(4):2146-52. PubMed ID: 16489015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathways targeting tumor lymphangiogenesis.
    Wissmann C; Detmar M
    Clin Cancer Res; 2006 Dec; 12(23):6865-8. PubMed ID: 17145802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
    He Y; Kozaki K; Karpanen T; Koshikawa K; Yla-Herttuala S; Takahashi T; Alitalo K
    J Natl Cancer Inst; 2002 Jun; 94(11):819-25. PubMed ID: 12048269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis.
    Hirakawa S; Kodama S; Kunstfeld R; Kajiya K; Brown LF; Detmar M
    J Exp Med; 2005 Apr; 201(7):1089-99. PubMed ID: 15809353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor lymphangiogenesis and metastatic spread-new players begin to emerge.
    Achen MG; Stacker SA
    Int J Cancer; 2006 Oct; 119(8):1755-60. PubMed ID: 16557570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation.
    Garmy-Susini B; Jin H; Zhu Y; Sung RJ; Hwang R; Varner J
    J Clin Invest; 2005 Jun; 115(6):1542-51. PubMed ID: 15902308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of FLT4 suppresses metastasis of melanoma cells by impaired lymphatic vessels.
    Lee JY; Hong SH; Shin M; Heo HR; Jang IH
    Biochem Biophys Res Commun; 2016 Sep; 478(2):733-8. PubMed ID: 27507214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway.
    Choi JU; Chung SW; Al-Hilal TA; Alam F; Park J; Mahmud F; Jeong JH; Kim SY; Byun Y
    Biomaterials; 2017 Sep; 139():56-66. PubMed ID: 28586719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-O-Acetyloleanolic acid inhibits VEGF-A-induced lymphangiogenesis and lymph node metastasis in an oral cancer sentinel lymph node animal model.
    Hwang-Bo J; Bae MG; Park JH; Chung IS
    BMC Cancer; 2018 Jul; 18(1):714. PubMed ID: 29976150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL27/CCL28-CCR10 Chemokine Signaling Mediates Migration of Lymphatic Endothelial Cells.
    Karnezis T; Farnsworth RH; Harris NC; Williams SP; Caesar C; Byrne DJ; Herle P; Macheda ML; Shayan R; Zhang YF; Yazar S; Takouridis SJ; Gerard C; Fox SB; Achen MG; Stacker SA
    Cancer Res; 2019 Apr; 79(7):1558-1572. PubMed ID: 30709930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis.
    Kopfstein L; Veikkola T; Djonov VG; Baeriswyl V; Schomber T; Strittmatter K; Stacker SA; Achen MG; Alitalo K; Christofori G
    Am J Pathol; 2007 Apr; 170(4):1348-61. PubMed ID: 17392173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.